Bell Investment Advisors, Inc Astrazeneca PLC Transaction History
Bell Investment Advisors, Inc
- $542 Million
- Q3 2024
A detailed history of Bell Investment Advisors, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 186 shares of AZN stock, worth $11,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186
Previous 186
-0.0%
Holding current value
$11,985
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...